Market Cap 123.38M
Revenue (ttm) 7.95M
Net Income (ttm) -21.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -267.04%
Debt to Equity Ratio 0.00
Volume 152,000
Avg Vol 160,912
Day's Range N/A - N/A
Shares Out 23.46M
Stochastic %K 73%
Beta 0.55
Analysts Strong Sell
Price Target $15.64

Company Profile

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 587 8170
Address:
5850 San Felipe St., Suite 500, Houston, United States
zampy
zampy May. 15 at 8:15 PM
$COYA Up 20% for the week good week...I believe $4.80 to $5.00 is a good area in my opinion.
1 · Reply
Jwa68
Jwa68 May. 15 at 6:07 PM
$GANX $COYA https://endpoints.news/biopharma-ma-maintains-strength-even-as-large-deals-wane/
0 · Reply
irf944
irf944 May. 15 at 2:42 PM
$COYA P&F chart update. These charts eliate alot of noise since it takes a considerbale amount of Selling/Buying to change from an "O" to an "X" (or vice versa).Coya had to go from $4 It actually went lower than $4) to $4.75 to change columns. That's a 19% move. Buyers/Demand are now in control which is denoted by "X" column which we just formed. This marks a chnage of hands form the selling we went tyhru, to buyers accumulating stock During this formation we also had higher lows, which is a good sign. Ince we get to $5.50 we will break the long term resistance line, and a double top break...that's 2 very Bullish signs. Our next diuble top isn't until $7.50 Would not be surprised to see some consolidation after a very nice run up. Looking forward to the next move up which will break that resistance line. Company continues to deliver good news and with th elow float the stock can make some nice moves.
1 · Reply
VINCE_CARTER
VINCE_CARTER May. 15 at 2:41 PM
$COYA Very bullish post. When you have randoms posting on the board predicting 99% failure without any explanation, it screams fomo. You had months to get in sub $4.50
2 · Reply
zampy
zampy May. 15 at 2:23 PM
$COYA Today to be expected light volume...35k....In my opinion $4.85ish to $4.90 decent level...It will be fleeting.
0 · Reply
zampy
zampy May. 15 at 2:20 PM
$COYA 13F's: Renaissance Technologies ( Ren Tech) they are cinsudered the best hedge fund in history. From 1988 to 2018 Ren Tech averaged a whooping 66% a year!! Better than Lynch..Buffet..or Soros...called Medallion fund. They are quant guys not tupical Wall street guys..Physics types..genius minds. As of May 14th Ren Tech now has 104k shares they increased 55% for quarter ending March 31st. A good sign....It is possible they added in Aoril and May as we will know Aug 14th...
2 · Reply
Jwa68
Jwa68 May. 15 at 1:00 PM
1 · Reply
Jwa68
Jwa68 May. 15 at 12:54 PM
$COYA I continue to anticipate a likely acquisition in or around Sept, for what should now be many self evident reasons. While i wish we would make it to the Q1 data readout, I expect Reddy's will not want the data card turned over for fear of being outbid by large pharma.
0 · Reply
DonkeyClanbrands
DonkeyClanbrands May. 15 at 11:35 AM
$COYA i cant find it what was the colume yesterday?
1 · Reply
EmotionlessRobot
EmotionlessRobot May. 15 at 10:09 AM
$COYA To me this company is severely undervalued given all the factors in play. The data looks excellent, the management have been superb (the more I think about the recent ATM filing the more I see it as a confidence move for a much higher share price going forward into the summer months). However, there are some elements we need to be cautious of. First Dr Reddys provide half of the solution that makes up COYA 302. Their biosimilar Abatacept is not approved yet in the US. We don't require it to be approved as if a combination therapy works it doesn't usually require individual approval of each bio element, but if it was to have any setbacks in its current FDA approval application it would impact us no doubt (especially if related to safety, with manufacturing issues also being a risk). This would be a setback but nothing that wouldn't be solved long term imo. Another issue is the initial data. The drug works but will it work consistently on non-C9orf72 carrying patients?
1 · Reply
Latest News on COYA
Coya Therapeutics reports Q1 EPS (32c), consensus (39c)

2026-05-12T11:49:47.000Z - 3 days ago

Coya Therapeutics reports Q1 EPS (32c), consensus (39c)


Coya Therapeutics Executive Chairman Howard Berman steps down

2026-04-02T12:17:50.000Z - 6 weeks ago

Coya Therapeutics Executive Chairman Howard Berman steps down


Coya Therapeutics Transcript: Status update

Feb 17, 2026, 3:00 PM EST - 3 months ago

Coya Therapeutics Transcript: Status update


Coya Therapeutics Announces $11.1 Million Private Placement

Jan 30, 2026, 8:00 AM EST - 3 months ago

Coya Therapeutics Announces $11.1 Million Private Placement


Coya Therapeutics commences dosing in ALSTARS trial

2025-12-09T13:11:58.000Z - 5 months ago

Coya Therapeutics commences dosing in ALSTARS trial


Coya Therapeutics reports Q3 EPS (13c), consensus (30c)

2025-11-12T13:20:43.000Z - 6 months ago

Coya Therapeutics reports Q3 EPS (13c), consensus (30c)


Coya Therapeutics 3.64M Spot Secondary priced at $5.50

2025-10-24T10:35:20.000Z - 7 months ago

Coya Therapeutics 3.64M Spot Secondary priced at $5.50


Coya Therapeutics Transcript: Study Update

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Coya Therapeutics Transcript: Study Update


zampy
zampy May. 15 at 8:15 PM
$COYA Up 20% for the week good week...I believe $4.80 to $5.00 is a good area in my opinion.
1 · Reply
Jwa68
Jwa68 May. 15 at 6:07 PM
$GANX $COYA https://endpoints.news/biopharma-ma-maintains-strength-even-as-large-deals-wane/
0 · Reply
irf944
irf944 May. 15 at 2:42 PM
$COYA P&F chart update. These charts eliate alot of noise since it takes a considerbale amount of Selling/Buying to change from an "O" to an "X" (or vice versa).Coya had to go from $4 It actually went lower than $4) to $4.75 to change columns. That's a 19% move. Buyers/Demand are now in control which is denoted by "X" column which we just formed. This marks a chnage of hands form the selling we went tyhru, to buyers accumulating stock During this formation we also had higher lows, which is a good sign. Ince we get to $5.50 we will break the long term resistance line, and a double top break...that's 2 very Bullish signs. Our next diuble top isn't until $7.50 Would not be surprised to see some consolidation after a very nice run up. Looking forward to the next move up which will break that resistance line. Company continues to deliver good news and with th elow float the stock can make some nice moves.
1 · Reply
VINCE_CARTER
VINCE_CARTER May. 15 at 2:41 PM
$COYA Very bullish post. When you have randoms posting on the board predicting 99% failure without any explanation, it screams fomo. You had months to get in sub $4.50
2 · Reply
zampy
zampy May. 15 at 2:23 PM
$COYA Today to be expected light volume...35k....In my opinion $4.85ish to $4.90 decent level...It will be fleeting.
0 · Reply
zampy
zampy May. 15 at 2:20 PM
$COYA 13F's: Renaissance Technologies ( Ren Tech) they are cinsudered the best hedge fund in history. From 1988 to 2018 Ren Tech averaged a whooping 66% a year!! Better than Lynch..Buffet..or Soros...called Medallion fund. They are quant guys not tupical Wall street guys..Physics types..genius minds. As of May 14th Ren Tech now has 104k shares they increased 55% for quarter ending March 31st. A good sign....It is possible they added in Aoril and May as we will know Aug 14th...
2 · Reply
Jwa68
Jwa68 May. 15 at 1:00 PM
1 · Reply
Jwa68
Jwa68 May. 15 at 12:54 PM
$COYA I continue to anticipate a likely acquisition in or around Sept, for what should now be many self evident reasons. While i wish we would make it to the Q1 data readout, I expect Reddy's will not want the data card turned over for fear of being outbid by large pharma.
0 · Reply
DonkeyClanbrands
DonkeyClanbrands May. 15 at 11:35 AM
$COYA i cant find it what was the colume yesterday?
1 · Reply
EmotionlessRobot
EmotionlessRobot May. 15 at 10:09 AM
$COYA To me this company is severely undervalued given all the factors in play. The data looks excellent, the management have been superb (the more I think about the recent ATM filing the more I see it as a confidence move for a much higher share price going forward into the summer months). However, there are some elements we need to be cautious of. First Dr Reddys provide half of the solution that makes up COYA 302. Their biosimilar Abatacept is not approved yet in the US. We don't require it to be approved as if a combination therapy works it doesn't usually require individual approval of each bio element, but if it was to have any setbacks in its current FDA approval application it would impact us no doubt (especially if related to safety, with manufacturing issues also being a risk). This would be a setback but nothing that wouldn't be solved long term imo. Another issue is the initial data. The drug works but will it work consistently on non-C9orf72 carrying patients?
1 · Reply
Sirloinsteak
Sirloinsteak May. 15 at 10:05 AM
$COYA I own shares more to support the efforts to find a good treatment for the horrible ALS than just cynical cashing out .....long COYA
0 · Reply
Jwa68
Jwa68 May. 15 at 3:53 AM
$COYA https://www.streetwisereports.com/article/2026/05/12/fda-fast-track-designation-boosts-als-treatment-outlook-analyst-sees-more-than-250-upside-potential.html
0 · Reply
Florestan
Florestan May. 15 at 2:26 AM
$COYA less than 1% of my book is in this name. 99% chance it fails but if it works, 100x. No need to overwork yourself here.
1 · Reply
Apiker
Apiker May. 15 at 1:05 AM
$COYA 👀
0 · Reply
zampy
zampy May. 15 at 12:22 AM
$COYA 13F's come tomorrow on Edgar between 10am to 5 30pm....Lets see if Wallace increased or the NY METS owner Stevie Cohen who had a modest position of 70k shares.... We will see a few names in my opinion...Maybe VanGuard added we will see.
0 · Reply
foreverboner
foreverboner May. 14 at 10:27 PM
$COYA +21K up volume. most since March '24
0 · Reply
topstockalerts
topstockalerts May. 14 at 10:04 PM
$COYA the stock is behaving like supply is drying up.
0 · Reply
Jwa68
Jwa68 May. 14 at 9:15 PM
$COYA Nice shout out at the 2:50 mark. https://youtu.be/KWgxbrz8dtg?si=jO0djJM1memLodhE
3 · Reply
zampy
zampy May. 14 at 8:31 PM
$COYA Ya play the guitar on the MTV!!!
1 · Reply
Vermicelli_
Vermicelli_ May. 14 at 7:17 PM
$COYA It was only two days ago when it was granted FDA fast track and it dipped under $4. I was like what??? Then I said, “yes please” and didn’t think twice about picking up some more shares. Congrats longs!!!
2 · Reply
Will2ride1
Will2ride1 May. 14 at 7:10 PM
$COYA if this company has a cure for dementia or ALS the price goes into and through the stratosphere 🚀
2 · Reply
Chrissytina
Chrissytina May. 14 at 6:37 PM
$COYA Here comes…
0 · Reply